Skip to main content
. 2022 Aug 10;83:104211. doi: 10.1016/j.ebiom.2022.104211

Table 2.

Demographical and clinical characteristics of patients and control population.

Critically ill patients Mildly affected patients
General characteristics N Mean±DS Range N Mean±DS Range
Age 23 69.8±10.9 48-88 16 51.8±10.1 29-64
Gender
 Man
Women		 18(78.2%)
5(21.7%)		 9(56.25%)
7(43.75%)
Chronicdiseases
  • -

    Heart disease

  • -

    Hypertension

  • -

    Diabetes

  • -

    Asthma

  • -

    COPD

  • -

    Hypothyroidism

  • -

    Renalfailure

 7 (30.4%)
18(78.3%)
8 (34.8%)
3 (13.6%)
2(8.7%)
2 (8.7%)
4 (17.4%)		 0
3(18%)
0
0
0
0
0
Neurological symptoms
  • -

    Delirium

  • -

    Myoclonus

  • -

    Seizures

  • -

    Nystagmus

  • -

    Dystonia

  • -

    Ataxia

  • -

    Apraxia

  • -

    Aphasia

 16(100%)
7(30%)
6(26%)
3(13%)
1(4%)
1(4%)
1(4%)
1(4%)
_
Days onset COVID-19/onset neurological symptoms 23 18.6±12.9 0–43 _
Other COVID19 symptoms
  • -

    Fever

  • -

    Cough

  • -

    Dyspnoea

 23(100%)
23(100%)
23(100%)		 7(44%)
5(31%)
0
Days onset COVID-19/discharge/negativisation 23 45.0±30.8 13–160 16 17.0±10.1 6–43
Days onset COVID-19/admission to the hospital 23 6.3±3.7
0–16		 _
Days onset COVID-19/admission to ICU 23 7.2±3.5
2–16		 _
Days on ICU 23 34.1±21.4
5–77		 _
PCO2 ICU admission 23 37.9±13.1 28–74.6
PO2 ICU admission 23 87.9±36.4
49.6–212		 _